Universal Health Services, Inc.
UHS · New York Stock Exchange · USD
194,46USD
−0,96 (−0,49 %)Stand 11. Nov., 17:34
Kennzahlen
- Eröffnung
- 193,03
- Vortag
- 195,41
- Tagesspanne
- 191,02 – 195,21
- 52 Wochen
- 140,08 – 246,33
- Volumen
- 142.571
- Ø Volumen
- 780.596
- Börsenwert
- 10,05 Mrd. $
- KGV
- 8,1
- Gewinn je Aktie (TTM)
- 23,86
- Dividendenrendite
- 0,4 %
- Beta
- 1,1
- Nächste Zahlen
- 24. Feb. 2027
Finanzen
| USD | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Umsatz | 17,36 Mrd. | 15,83 Mrd. | 14,28 Mrd. | 13,4 Mrd. | 12,64 Mrd. |
| Herstellungskosten | 1,66 Mrd. | 1,59 Mrd. | 1,53 Mrd. | 1,47 Mrd. | 1,43 Mrd. |
| Bruttogewinn | 15,71 Mrd. | 14,24 Mrd. | 12,75 Mrd. | 11,93 Mrd. | 11,21 Mrd. |
| Forschung und Entwicklung | 0 | 0 | 0 | 0 | 0 |
| Vertrieb und Verwaltung | 8,23 Mrd. | 7,67 Mrd. | 7,25 Mrd. | 6,89 Mrd. | 6,28 Mrd. |
| Operatives Ergebnis | 1,99 Mrd. | 1,68 Mrd. | 1,18 Mrd. | 1 Mrd. | 1,36 Mrd. |
| EBITDA | 2,74 Mrd. | 2,27 Mrd. | 1,72 Mrd. | 1,58 Mrd. | 1,91 Mrd. |
| Nettogewinn | 1,49 Mrd. | 1,14 Mrd. | 717,8 Mio. | 675,61 Mio. | 991,59 Mio. |
| Gewinn je Aktie (verwässert) | 23,10 | 16,82 | 10,23 | 9,14 | 11,82 |
Umsatz nach Segment
Produkte · FY 2025
- Acute Care Hospital Services9,93 Mrd. $57,21 %+11,25 %
- Behavioral Health Services7,43 Mrd. $42,79 %+7,69 %
Anteil · ggü. Vorjahr (FY 2024)
Regionen · FY 2023
- Behavioral Health Services761 Mio. $100,00 %+11,09 %
Anteil · ggü. Vorjahr (FY 2022)
Bewertung
Letzte 12 Monate
- KGV
- 8,1
- Kurs-Umsatz-Verhältnis
- 0,5
- Kurs-Buchwert-Verhältnis
- 1,5
- PEG
- 0,6
- Bruttomarge
- 69,8 %
- Operative Marge
- 10,8 %
- Nettomarge
- 8,0 %
- Verschuldungsgrad
- 0,8
- EV/EBITDA
- 5,8
- Eigenkapitalrendite
- 19,5 %
- Kapitalrendite (ROIC)
- 10,4 %
- Free-Cashflow-Rendite
- 11,1 %
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |
|---|---|---|---|---|---|
| Bruttomarge | 90,4 % | 90,0 % | 89,3 % | 89,0 % | 88,7 % |
| Operative Marge | 11,5 % | 10,6 % | 8,2 % | 7,5 % | 10,8 % |
| Nettomarge | 8,6 % | 7,2 % | 5,0 % | 5,0 % | 7,8 % |
| KGV | 9,3 | 10,5 | 14,7 | 15,3 | 10,8 |
| Kurs-Umsatz-Verhältnis | 0,8 | 0,8 | 0,7 | 0,8 | 0,8 |
| Kurs-Buchwert-Verhältnis | 1,9 | 1,8 | 1,7 | 1,7 | 1,8 |
| Verschuldungsgrad | 0,8 | 0,7 | 0,9 | 0,9 | 0,7 |
| Liquidität 3. Grades | 1,1 | 1,3 | 1,4 | 1,3 | 1,1 |
| Dividendenrendite | 0,4 % | 0,4 % | 0,5 % | 0,6 % | 0,6 % |
| Unternehmenswert | 19,23 Mrd. | 16,77 Mrd. | 15,81 Mrd. | 15,47 Mrd. | 15,14 Mrd. |
| EV/EBITDA | 7,0 | 7,4 | 9,2 | 9,8 | 7,9 |
| Eigenkapitalrendite | 20,5 % | 17,1 % | 11,7 % | 11,4 % | 16,3 % |
| Kapitalrendite (ROIC) | 11,3 % | 10,6 % | 7,4 % | 6,5 % | 9,3 % |
| Free-Cashflow-Rendite | 6,1 % | 9,4 % | 5,0 % | 2,5 % | 0,3 % |
Wachstum
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |
|---|---|---|---|---|---|
| Umsatz | +9,7 % | +10,8 % | +6,6 % | +6,0 % | +9,4 % |
| Bruttogewinn | +10,3 % | +11,7 % | +6,9 % | +6,3 % | +9,2 % |
| Operatives Ergebnis | +18,6 % | +43,1 % | +17,1 % | −26,4 % | +0,3 % |
| Nettogewinn | +30,4 % | +59,1 % | +6,2 % | −31,9 % | +5,0 % |
| Gewinn je Aktie | +37,3 % | +64,4 % | +11,9 % | −22,7 % | +7,6 % |
| Freier Cashflow | −24,4 % | +114,1 % | +100,3 % | +834,6 % | −98,3 % |
| Dividende je Aktie | +0,6 % | +0,2 % | +0,1 % | +0,1 % | +291,6 % |
Analysten
Einstufungen · Hold
- 0Stark kaufen
- 17Kaufen
- 25Halten
- 2Verkaufen
- 0Stark verkaufen
Kursziel
193,13
Durchschnitt · −0,68 %
Schätzungen
| FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|
| Umsatz (Ø) | 18,61 Mrd. | 19,48 Mrd. | 20,32 Mrd. |
| Umsatz (Tief – Hoch) | 18,53 Mrd. – 18,69 Mrd. | 19,28 Mrd. – 19,75 Mrd. | 19,64 Mrd. – 21,08 Mrd. |
| Gewinn je Aktie (Ø) | 22,40 | 22,98 | 24,84 |
| Gewinn je Aktie (Tief – Hoch) | 22,15 – 22,83 | 21,97 – 24,34 | 22,24 – 27,24 |
| Analysten | 10 | 12 | 9 |
Letzte Änderungen
- Wells Fargo2. Nov. 2026Equal Weight
- Guggenheim29. Okt. 2026Buy
- Baird29. Okt. 2026Neutral
- Leerink Partners18. Sept. 2026Outperform
- RBC Capital20. Aug. 2026Sector Perform
- RBC Capital3. Aug. 2026Sector Perform
- Goldman Sachs30. Juli 2026Neutral
- Baird29. Juli 2026Neutral
Quartalszahlen
Nächste Zahlen: 24. Feb. 2027| Okt. 2026 | Juli 2026 | Apr. 2026 | Feb. 2026 | Okt. 2025 | Juli 2025 | Apr. 2025 | Feb. 2025 | |
|---|---|---|---|---|---|---|---|---|
| Gewinn je Aktie · Erwartet | 5,19 | 5,94 | 5,41 | 5,92 | 4,66 | 4,92 | 4,35 | 4,21 |
| Gewinn je Aktie · Tatsächlich | 5,22 | 5,98 | 5,62 | 5,88 | 5,69 | 5,35 | 4,84 | 4,92 |
| Abweichung | +0,58 % | +0,67 % | +3,88 % | −0,68 % | +22,10 % | +8,74 % | +11,26 % | +16,86 % |
| Umsatz · Tatsächlich | 4,73 Mrd. | 4,64 Mrd. | 4,5 Mrd. | 4,49 Mrd. | 4,5 Mrd. | 4,28 Mrd. | 4,1 Mrd. | 4,11 Mrd. |
Dividenden und Splits
| Ex-Tag | Zahltag | Betrag |
|---|---|---|
| 1. Sept. 2026 | 15. Sept. 2026 | 0,20 |
| 8. Juni 2026 | 18. Juni 2026 | 0,20 |
| 2. März 2026 | 16. März 2026 | 0,20 |
| 1. Dez. 2025 | 15. Dez. 2025 | 0,20 |
| 2. Sept. 2025 | 16. Sept. 2025 | 0,20 |
| 2. Juni 2025 | 16. Juni 2025 | 0,20 |
| 3. März 2025 | 17. März 2025 | 0,20 |
| 3. Dez. 2024 | 17. Dez. 2024 | 0,20 |
| 3. Sept. 2024 | 17. Sept. 2024 | 0,20 |
| 3. Juni 2024 | 17. Juni 2024 | 0,20 |
| 29. Feb. 2024 | 15. März 2024 | 0,20 |
| 30. Nov. 2023 | 15. Dez. 2023 | 0,20 |
Aktiensplits
- 16. Dez. 20092:1
- 4. Juni 20012:1
- 20. Mai 19962:1
- 5. Juli 19832:1
Eigentümer
Institutionen
Q2 2026 · 13F
- Anteil institutioneller Investoren
- 86,52 %
- Investoren mit 13F-Meldung
- 618
Größte Investoren
- FIRST EAGLE INVESTMENT MANAGEMENT, LLC7,64 %4,55 Mio.
- BLACKROCK, INC.6,81 %4,06 Mio.
- VANGUARD CAPITAL MANAGEMENT LLC5,69 %3,39 Mio.
- VANGUARD PORTFOLIO MANAGEMENT LLC4,11 %2,45 Mio.
- DIMENSIONAL FUND ADVISORS LP3,71 %2,21 Mio.
- STATE STREET CORP3,44 %2,1 Mio.
- GEODE CAPITAL MANAGEMENT, LLC3,31 %1,97 Mio.
- PZENA INVESTMENT MANAGEMENT LLC3,30 %1,97 Mio.
Insider-Geschäfte
- MILLER ALAN B27. Mai 2026 · director, 10 percent owner, officer: Executive ChairmanKauf14.163 Aktien
- MILLER ALAN B27. Mai 2026 · director, 10 percent owner, officer: Executive ChairmanKauf14.163 Aktien
- MILLER ALAN B27. Mai 2026 · director, 10 percent owner, officer: Executive ChairmanKauf14.163 Aktien
- MILLER ALAN B27. Mai 2026 · director, 10 percent owner, officer: Executive ChairmanKauf9418 Aktien
- MILLER ALAN B27. Mai 2026 · director, 10 percent owner, officer: Executive ChairmanVerkauf50.990 Aktien
- MILLER ALAN B27. Mai 2026 · director, 10 percent owner, officer: Executive ChairmanKauf9418 Aktien
- MILLER ALAN B27. Mai 2026 · director, 10 percent owner, officer: Executive ChairmanKauf13.963 Aktien
- MILLER ALAN B27. Mai 2026 · director, 10 percent owner, officer: Executive ChairmanVerkauf25.495 Aktien
Vergleichbare Unternehmen
ACHCAcadia Healthcare Company, Inc.38,41−0,59 %
ARDTArdent Health Inc.18,12+1,03 %
CHEChemed Corporation544,32−0,03 %
CYHCommunity Health Systems, Inc.2,165−0,23 %
FMSFresenius Medical Care AG & Co. KGaA22,17−2,53 %
FSNUYFresenius SE & Co. KGaA14,66−2,20 %
HCAHCA Healthcare, Inc.499,33−1,01 %
NUTXNutex Health, Inc.191,77+2,96 %
Über das Unternehmen
Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.
Führung
- Marc D. MillerChief Executive Officer, President & Director
- Alan MillerFounder & Executive Chairman of the Board
- Steve G. FiltonExecutive Vice President, Chief Financial Officer & Secretary
- Edward H. SimExecutive Vice President & President of Acute Care Division
- Darren LehrichVice President of Investor Relations
- Jim ClarkSenior Vice President of Finance - Acute Care Division
- CEO
- Marc D. Miller
- Mitarbeitende
- 102.000
- Hauptsitz
- King of Prussia, PA, US
- Sektor
- Healthcare
- Branche
- Medical - Care Facilities
- Börsengang
- 9. Juli 1981
- Website
- uhs.com
Nachrichten
- Seeking Alpha · 10. Nov., 15:20Universal Health Services, Inc. (UHS) Presents at 2026 UBS Global Healthcare Conference Transcript
- Zacks Investment Research · 9. Nov., 11:01Do Options Traders Know Something About UHS Stock We Don't?
- 24/7 Wall Street · 5. Nov., 14:44Hospital Stocks Soared as Democrats Took Congress
- Barrons · 4. Nov., 13:16Healthcare Stocks Bounce on Midterm Results. A Bull Market Case Is Developing.
- GlobeNewsWire · 30. Okt., 16:09Universal Health Services, Inc. to Present at The UBS Global Healthcare Conference
- MarketBeat · 29. Okt., 5:05Universal Health Services Q3 Earnings Call Highlights
- Zacks Investment Research · 28. Okt., 16:45UHS Misses Q3 Earnings Estimates Despite Higher Patient Volumes
- Seeking Alpha · 28. Okt., 12:40Universal Health Services, Inc. (UHS) Q3 2026 Earnings Call Transcript
- Zacks Investment Research · 27. Okt., 21:01Compared to Estimates, Universal Health Services (UHS) Q3 Earnings: A Look at Key Metrics
- Zacks Investment Research · 27. Okt., 19:21Universal Health Services (UHS) Misses Q3 Earnings Estimates
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.